nodes	percent_of_prediction	percent_of_DWPC	metapath
Hyoscyamine—Myopia—Varenicline—nicotine dependence	0.077	0.0937	CcSEcCtD
Hyoscyamine—Balance disorder—Varenicline—nicotine dependence	0.0308	0.0374	CcSEcCtD
Hyoscyamine—Paranoia—Varenicline—nicotine dependence	0.0247	0.03	CcSEcCtD
Hyoscyamine—Mania—Varenicline—nicotine dependence	0.0231	0.0281	CcSEcCtD
Hyoscyamine—Mydriasis—Varenicline—nicotine dependence	0.0211	0.0256	CcSEcCtD
Hyoscyamine—Gastrooesophageal reflux disease—Varenicline—nicotine dependence	0.0186	0.0226	CcSEcCtD
Hyoscyamine—Ventricular extrasystoles—Varenicline—nicotine dependence	0.0186	0.0226	CcSEcCtD
Hyoscyamine—Leukocytosis—Varenicline—nicotine dependence	0.0179	0.0218	CcSEcCtD
Hyoscyamine—Dysarthria—Varenicline—nicotine dependence	0.0178	0.0216	CcSEcCtD
Hyoscyamine—Blood pressure increased—Varenicline—nicotine dependence	0.0168	0.0205	CcSEcCtD
Hyoscyamine—Photophobia—Varenicline—nicotine dependence	0.0158	0.0192	CcSEcCtD
Hyoscyamine—Dry eye—Varenicline—nicotine dependence	0.0155	0.0189	CcSEcCtD
Hyoscyamine—Hypertonia—Varenicline—nicotine dependence	0.0147	0.0179	CcSEcCtD
Hyoscyamine—Disorientation—Varenicline—nicotine dependence	0.0136	0.0166	CcSEcCtD
Hyoscyamine—Eczema—Varenicline—nicotine dependence	0.0136	0.0165	CcSEcCtD
Hyoscyamine—Eye pain—Varenicline—nicotine dependence	0.0135	0.0164	CcSEcCtD
Hyoscyamine—Amnesia—Varenicline—nicotine dependence	0.013	0.0158	CcSEcCtD
Hyoscyamine—Atrial fibrillation—Varenicline—nicotine dependence	0.0129	0.0157	CcSEcCtD
Hyoscyamine—Thirst—Varenicline—nicotine dependence	0.0128	0.0156	CcSEcCtD
Hyoscyamine—Hypoglycaemia—Varenicline—nicotine dependence	0.0125	0.0152	CcSEcCtD
Hyoscyamine—Lethargy—Varenicline—nicotine dependence	0.0125	0.0152	CcSEcCtD
Hyoscyamine—Osteoarthritis—Varenicline—nicotine dependence	0.0122	0.0148	CcSEcCtD
Hyoscyamine—Psychotic disorder—Varenicline—nicotine dependence	0.0119	0.0145	CcSEcCtD
Hyoscyamine—Irritability—Varenicline—nicotine dependence	0.0116	0.0142	CcSEcCtD
Hyoscyamine—Urinary retention—Varenicline—nicotine dependence	0.0116	0.0141	CcSEcCtD
Hyoscyamine—Dry skin—Varenicline—nicotine dependence	0.0112	0.0136	CcSEcCtD
Hyoscyamine—Hypokalaemia—Varenicline—nicotine dependence	0.0111	0.0135	CcSEcCtD
Hyoscyamine—Abdominal distension—Varenicline—nicotine dependence	0.0106	0.0129	CcSEcCtD
Hyoscyamine—Dysphagia—Varenicline—nicotine dependence	0.0105	0.0128	CcSEcCtD
Hyoscyamine—Angina pectoris—Varenicline—nicotine dependence	0.0103	0.0125	CcSEcCtD
Hyoscyamine—Erectile dysfunction—Varenicline—nicotine dependence	0.00972	0.0118	CcSEcCtD
Hyoscyamine—Hyperglycaemia—Varenicline—nicotine dependence	0.00952	0.0116	CcSEcCtD
Hyoscyamine—Depression—Varenicline—nicotine dependence	0.00938	0.0114	CcSEcCtD
Hyoscyamine—Acute coronary syndrome—Varenicline—nicotine dependence	0.00927	0.0113	CcSEcCtD
Hyoscyamine—Myocardial infarction—Varenicline—nicotine dependence	0.00922	0.0112	CcSEcCtD
Hyoscyamine—Conjunctivitis—Varenicline—nicotine dependence	0.00914	0.0111	CcSEcCtD
Hyoscyamine—Bradycardia—Varenicline—nicotine dependence	0.0086	0.0105	CcSEcCtD
Hyoscyamine—Hallucination—Varenicline—nicotine dependence	0.0084	0.0102	CcSEcCtD
Hyoscyamine—Arrhythmia—Varenicline—nicotine dependence	0.00754	0.00918	CcSEcCtD
Hyoscyamine—CHRM4—Monoamine GPCRs—DRD2—nicotine dependence	0.00753	0.0423	CbGpPWpGaD
Hyoscyamine—Mental disorder—Varenicline—nicotine dependence	0.0074	0.009	CcSEcCtD
Hyoscyamine—Erythema—Varenicline—nicotine dependence	0.00735	0.00894	CcSEcCtD
Hyoscyamine—Dysgeusia—Varenicline—nicotine dependence	0.0072	0.00876	CcSEcCtD
Hyoscyamine—Vision blurred—Varenicline—nicotine dependence	0.00693	0.00843	CcSEcCtD
Hyoscyamine—Agitation—Varenicline—nicotine dependence	0.00675	0.00822	CcSEcCtD
Hyoscyamine—Angioedema—Varenicline—nicotine dependence	0.00672	0.00817	CcSEcCtD
Hyoscyamine—Vertigo—Varenicline—nicotine dependence	0.0066	0.00803	CcSEcCtD
Hyoscyamine—Syncope—Varenicline—nicotine dependence	0.00659	0.00802	CcSEcCtD
Hyoscyamine—Palpitations—Varenicline—nicotine dependence	0.0065	0.0079	CcSEcCtD
Hyoscyamine—Loss of consciousness—Varenicline—nicotine dependence	0.00646	0.00786	CcSEcCtD
Hyoscyamine—Convulsion—Varenicline—nicotine dependence	0.00637	0.00775	CcSEcCtD
Hyoscyamine—CHRM4—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00633	0.0356	CbGpPWpGaD
Hyoscyamine—Chest pain—Varenicline—nicotine dependence	0.00626	0.00761	CcSEcCtD
Hyoscyamine—Anxiety—Varenicline—nicotine dependence	0.00624	0.00759	CcSEcCtD
Hyoscyamine—Dry mouth—Varenicline—nicotine dependence	0.00612	0.00745	CcSEcCtD
Hyoscyamine—Oedema—Varenicline—nicotine dependence	0.006	0.0073	CcSEcCtD
Hyoscyamine—Shock—Varenicline—nicotine dependence	0.0059	0.00718	CcSEcCtD
Hyoscyamine—Tachycardia—Varenicline—nicotine dependence	0.00585	0.00712	CcSEcCtD
Hyoscyamine—CHRM4—Regulation of Actin Cytoskeleton—FGD1—nicotine dependence	0.00581	0.0326	CbGpPWpGaD
Hyoscyamine—Hyperhidrosis—Varenicline—nicotine dependence	0.0058	0.00706	CcSEcCtD
Hyoscyamine—Hypotension—Varenicline—nicotine dependence	0.00561	0.00682	CcSEcCtD
Hyoscyamine—Insomnia—Varenicline—nicotine dependence	0.00543	0.0066	CcSEcCtD
Hyoscyamine—Dyspnoea—Varenicline—nicotine dependence	0.00535	0.00651	CcSEcCtD
Hyoscyamine—Somnolence—Varenicline—nicotine dependence	0.00533	0.00649	CcSEcCtD
Hyoscyamine—Dyspepsia—Varenicline—nicotine dependence	0.00528	0.00642	CcSEcCtD
Hyoscyamine—Fatigue—Varenicline—nicotine dependence	0.00517	0.00629	CcSEcCtD
Hyoscyamine—CHRM4—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.00514	0.0289	CbGpPWpGaD
Hyoscyamine—Constipation—Varenicline—nicotine dependence	0.00513	0.00624	CcSEcCtD
Hyoscyamine—Pain—Varenicline—nicotine dependence	0.00513	0.00624	CcSEcCtD
Hyoscyamine—CHRM1—Monoamine GPCRs—DRD2—nicotine dependence	0.00508	0.0285	CbGpPWpGaD
Hyoscyamine—CHRM3—Monoamine GPCRs—DRD2—nicotine dependence	0.00506	0.0284	CbGpPWpGaD
Hyoscyamine—CHRM2—Monoamine GPCRs—DRD2—nicotine dependence	0.00501	0.0282	CbGpPWpGaD
Hyoscyamine—Feeling abnormal—Varenicline—nicotine dependence	0.00494	0.00601	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Varenicline—nicotine dependence	0.00491	0.00597	CcSEcCtD
Hyoscyamine—Urticaria—Varenicline—nicotine dependence	0.00477	0.0058	CcSEcCtD
Hyoscyamine—Abdominal pain—Varenicline—nicotine dependence	0.00474	0.00577	CcSEcCtD
Hyoscyamine—Body temperature increased—Varenicline—nicotine dependence	0.00474	0.00577	CcSEcCtD
Hyoscyamine—Hypersensitivity—Varenicline—nicotine dependence	0.00442	0.00538	CcSEcCtD
Hyoscyamine—Asthenia—Varenicline—nicotine dependence	0.0043	0.00524	CcSEcCtD
Hyoscyamine—CHRM1—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00427	0.024	CbGpPWpGaD
Hyoscyamine—CHRM3—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00426	0.0239	CbGpPWpGaD
Hyoscyamine—Pruritus—Varenicline—nicotine dependence	0.00424	0.00516	CcSEcCtD
Hyoscyamine—CHRM2—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00421	0.0237	CbGpPWpGaD
Hyoscyamine—Diarrhoea—Varenicline—nicotine dependence	0.0041	0.00499	CcSEcCtD
Hyoscyamine—Dizziness—Varenicline—nicotine dependence	0.00397	0.00483	CcSEcCtD
Hyoscyamine—CHRM1—Regulation of Actin Cytoskeleton—FGD1—nicotine dependence	0.00392	0.022	CbGpPWpGaD
Hyoscyamine—CHRM3—Regulation of Actin Cytoskeleton—FGD1—nicotine dependence	0.0039	0.0219	CbGpPWpGaD
Hyoscyamine—CHRM2—Regulation of Actin Cytoskeleton—FGD1—nicotine dependence	0.00386	0.0217	CbGpPWpGaD
Hyoscyamine—Vomiting—Varenicline—nicotine dependence	0.00381	0.00464	CcSEcCtD
Hyoscyamine—Rash—Varenicline—nicotine dependence	0.00378	0.0046	CcSEcCtD
Hyoscyamine—Dermatitis—Varenicline—nicotine dependence	0.00378	0.0046	CcSEcCtD
Hyoscyamine—Headache—Varenicline—nicotine dependence	0.00376	0.00457	CcSEcCtD
Hyoscyamine—CHRM4—Regulation of Actin Cytoskeleton—WASF2—nicotine dependence	0.00361	0.0203	CbGpPWpGaD
Hyoscyamine—Nausea—Varenicline—nicotine dependence	0.00356	0.00434	CcSEcCtD
Hyoscyamine—CHRM4—Regulation of Actin Cytoskeleton—WASF1—nicotine dependence	0.00346	0.0195	CbGpPWpGaD
Hyoscyamine—CHRM2—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.00342	0.0192	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR ligand binding—TAS2R16—nicotine dependence	0.00311	0.0175	CbGpPWpGaD
Hyoscyamine—CHRM2—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.00293	0.0165	CbGpPWpGaD
Hyoscyamine—CHRM1—Regulation of Actin Cytoskeleton—WASF2—nicotine dependence	0.00244	0.0137	CbGpPWpGaD
Hyoscyamine—CHRM3—Regulation of Actin Cytoskeleton—WASF2—nicotine dependence	0.00243	0.0136	CbGpPWpGaD
Hyoscyamine—CHRM2—Regulation of Actin Cytoskeleton—WASF2—nicotine dependence	0.00241	0.0135	CbGpPWpGaD
Hyoscyamine—CHRM1—Regulation of Actin Cytoskeleton—WASF1—nicotine dependence	0.00234	0.0131	CbGpPWpGaD
Hyoscyamine—CHRM3—Regulation of Actin Cytoskeleton—WASF1—nicotine dependence	0.00233	0.0131	CbGpPWpGaD
Hyoscyamine—CHRM2—Regulation of Actin Cytoskeleton—WASF1—nicotine dependence	0.00231	0.013	CbGpPWpGaD
Hyoscyamine—CHRM4—G alpha (i) signalling events—OPRM1—nicotine dependence	0.00217	0.0122	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR ligand binding—TAS2R16—nicotine dependence	0.0021	0.0118	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR ligand binding—TAS2R16—nicotine dependence	0.00209	0.0117	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR ligand binding—TAS2R16—nicotine dependence	0.00207	0.0116	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00201	0.0113	CbGpPWpGaD
Hyoscyamine—CHRM2—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.00196	0.011	CbGpPWpGaD
Hyoscyamine—CHRM2—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.00178	0.00998	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00176	0.00988	CbGpPWpGaD
Hyoscyamine—CHRM4—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00172	0.00967	CbGpPWpGaD
Hyoscyamine—CHRM1—Circadian rythm related genes—CHRNB2—nicotine dependence	0.00162	0.00909	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—TAS2R16—nicotine dependence	0.0016	0.00897	CbGpPWpGaD
Hyoscyamine—CHRM4—G alpha (i) signalling events—DRD2—nicotine dependence	0.00157	0.0088	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00145	0.00816	CbGpPWpGaD
Hyoscyamine—CHRM2—G alpha (i) signalling events—OPRM1—nicotine dependence	0.00144	0.0081	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR downstream signaling—FGD1—nicotine dependence	0.00138	0.00775	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00136	0.00761	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00135	0.00759	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00134	0.00752	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR ligand binding—OPRM1—nicotine dependence	0.00131	0.00737	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—FGD1—nicotine dependence	0.00125	0.00704	CbGpPWpGaD
Hyoscyamine—CHRM4—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00125	0.00699	CbGpPWpGaD
Hyoscyamine—CHRM1—Circadian rythm related genes—DRD2—nicotine dependence	0.0012	0.00672	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00119	0.00666	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00118	0.00664	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00117	0.00657	CbGpPWpGaD
Hyoscyamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00116	0.00652	CbGpPWpGaD
Hyoscyamine—CHRM3—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00116	0.0065	CbGpPWpGaD
Hyoscyamine—CHRM2—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00115	0.00644	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—TAS2R16—nicotine dependence	0.00108	0.00605	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—TAS2R16—nicotine dependence	0.00107	0.00603	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—TAS2R16—nicotine dependence	0.00106	0.00597	CbGpPWpGaD
Hyoscyamine—CHRM2—G alpha (i) signalling events—DRD2—nicotine dependence	0.00104	0.00585	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00098	0.0055	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000977	0.00549	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000968	0.00543	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR ligand binding—DRD2—nicotine dependence	0.000948	0.00533	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—TAS2R16—nicotine dependence	0.000943	0.0053	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—FGD1—nicotine dependence	0.00093	0.00523	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—FGD1—nicotine dependence	0.000927	0.00521	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—FGD1—nicotine dependence	0.000918	0.00516	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR ligand binding—OPRM1—nicotine dependence	0.000884	0.00497	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR ligand binding—OPRM1—nicotine dependence	0.000882	0.00495	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR ligand binding—OPRM1—nicotine dependence	0.000873	0.0049	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—FGD1—nicotine dependence	0.000845	0.00474	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—FGD1—nicotine dependence	0.000842	0.00473	CbGpPWpGaD
Hyoscyamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00084	0.00472	CbGpPWpGaD
Hyoscyamine—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000837	0.0047	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—FGD1—nicotine dependence	0.000834	0.00468	CbGpPWpGaD
Hyoscyamine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000829	0.00466	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR downstream signaling—OPRM1—nicotine dependence	0.000741	0.00416	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—FGD1—nicotine dependence	0.00074	0.00416	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—OPRM1—nicotine dependence	0.000673	0.00378	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—AKR1B10—nicotine dependence	0.000654	0.00367	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR ligand binding—DRD2—nicotine dependence	0.000639	0.00359	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR ligand binding—DRD2—nicotine dependence	0.000637	0.00358	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—TAS2R16—nicotine dependence	0.000636	0.00357	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—TAS2R16—nicotine dependence	0.000634	0.00356	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR ligand binding—DRD2—nicotine dependence	0.000631	0.00354	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—TAS2R16—nicotine dependence	0.000628	0.00353	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR downstream signaling—DRD2—nicotine dependence	0.000536	0.00301	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—OPRM1—nicotine dependence	0.0005	0.00281	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—FGD1—nicotine dependence	0.000499	0.0028	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—OPRM1—nicotine dependence	0.000498	0.0028	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—FGD1—nicotine dependence	0.000498	0.00279	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—OPRM1—nicotine dependence	0.000493	0.00277	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—FGD1—nicotine dependence	0.000493	0.00277	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—CYP2A7—nicotine dependence	0.000489	0.00274	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—DRD2—nicotine dependence	0.000487	0.00273	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—WASF2—nicotine dependence	0.000461	0.00259	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—OPRM1—nicotine dependence	0.000454	0.00255	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—OPRM1—nicotine dependence	0.000452	0.00254	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—OPRM1—nicotine dependence	0.000448	0.00252	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—WASF1—nicotine dependence	0.000442	0.00248	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—AKR1B10—nicotine dependence	0.000441	0.00248	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—AKR1B10—nicotine dependence	0.000439	0.00247	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—AKR1B10—nicotine dependence	0.000435	0.00244	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—OPRM1—nicotine dependence	0.000398	0.00223	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—DRD2—nicotine dependence	0.000361	0.00203	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—DRD2—nicotine dependence	0.00036	0.00202	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—DRD2—nicotine dependence	0.000357	0.002	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—DRD2—nicotine dependence	0.000328	0.00184	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—DRD2—nicotine dependence	0.000327	0.00184	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—DRD2—nicotine dependence	0.000324	0.00182	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—WASF2—nicotine dependence	0.000311	0.00174	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—WASF2—nicotine dependence	0.00031	0.00174	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—WASF2—nicotine dependence	0.000307	0.00172	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—WASF1—nicotine dependence	0.000298	0.00167	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—WASF1—nicotine dependence	0.000297	0.00167	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—WASF1—nicotine dependence	0.000294	0.00165	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—DRD2—nicotine dependence	0.000288	0.00161	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—OPRM1—nicotine dependence	0.000268	0.00151	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—OPRM1—nicotine dependence	0.000267	0.0015	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—OPRM1—nicotine dependence	0.000265	0.00149	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—DRD2—nicotine dependence	0.000194	0.00109	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—DRD2—nicotine dependence	0.000193	0.00109	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—DRD2—nicotine dependence	0.000191	0.00107	CbGpPWpGaD
